Countries North America

Sartorius completes acquisition of Polyplus

Polyplus is a leading provider of innovative technologies for cell and gene therapies. Transfection reagents developed and produced by Polyplus are key com...

 July 18, 2023 | News

Scribe Therapeutics and Sanofi Team Up to Advance In Vivo Genetic Medicines for Sickle Cell and Genomic Disease

Predicated on the progress of the companies’ first collaboration, Sanofi has selected Scribe’s novel CRISPR by Design™ approach to driv...

 July 18, 2023 | News

Antengene Administers First Patient in US Clinical Study of ATG-017 for Advanced Solid Tumors with Nivolumab Combination

-  ATG-017 is an oral, potent and selective small molecule ERK1/2 inhibitor. Antengene has exclusive global rights to develop...

 July 18, 2023 | News

VitaDAO Launches VITA-FAST Tokens, Revolutionizing Governance in Longevity Research

The VITA-FAST tokens, which allow holders to make decisions on IP licensing, set experiment priorities, and govern research on autophagy, have been met wit...

 July 11, 2023 | News

Innovent and IASO Bio Receive NMPA Approval for FUCASO®, a Fully-human BCMA CAR-T Therapy for Multiple Myeloma

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

 July 03, 2023 | News

GenScript Debuts AmMag™ Quatro to Revolutionize Automated Plasmid Maxi-Prep Purification

 GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has added the AmMag™ Quatro a...

 June 21, 2023 | News

Bristol Myers Squibb Receives U.S. FDA Approval of New State-of-the-Art Cell Therapy Manufacturing Facility

Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved commercial production at the compa...

 June 09, 2023 | News

Merck Announces Proteologix as Winner of its North American Advance Biotech Grant

Proteologix to receive in-kind products and services to develop treatments for autoimmune/inflammatory diseases and oncology indications Experts from Me...

 June 07, 2023 | News

Samsung Biologics Hastens Timeline for New Plant, Aiming for April 2025 Launch

Samsung Biologics will maintain the world's largest biomanufacturing capacity at 784,000 liters upon completion of the newest plant- Key features of Plant ...

 June 07, 2023 | News

Immorna Initiates Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Shingles Vaccine

"The initiation of our FIH study with JCXH-105 is an important milestone for Immorna and for the development of a potential innovative vaccine for Shingles...

 May 31, 2023 | News

Amplo Biotech Secures Fast Track Funding for Promising Gene Therapy Targeting Collagen Q Deficiency

Under an exclusive licensing agreement, Amplo Biotechnology has gained access to AAV-ColQ data developed by Professor Kinji Ohno's laboratory at&...

 May 30, 2023 | News

Proteomedix Agrees to Issue Labcorp Exclusive License for Proclarix® Blood Test to Detect Prostate Cancer

Proteomedix, a Swiss diagnostics company committed to advancing prostate cancer care, announced today that it entered into an agreement for Labcorp, a...

 May 22, 2023 | News

Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility

Along with these additions to the site leadership team, the company has also appointed Erik Riley as Senior Vice President, Corporate Planning. T...

 May 19, 2023 | News

Antengene Clears U.S. IND for Phase I Trial of ATG-031 Antibody

-  ATG-031, discovered and developed in-house by Antengene, is the world's first anti-CD24 antibody to advance to the clinic in oncolog...

 May 18, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close